Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07462234 · ClinicalTrials.gov registry record

Continuous N-of-1 Computational Feasibility Study of a Whole Genome Sequence

A clinical trial of Computational Modeling of Individual Metabolic Pathways, sponsored by Bioactify.

Active
Registry status
1
Enrollment target
1
Study location

NCT07462234 is a study of Computational Modeling of Individual Metabolic Pathways that is active but no longer recruiting, run by Bioactify. The registered enrollment target is 1 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07462234, a study of Computational Modeling of Individual Metabolic Pathways, is active but no longer recruiting, sponsored by Bioactify.

ACTIVE NOT RECRUITING
Registry status
1 participants
Enrollment target
1
Study location

Study Summary

This is an observational, computational N-of-1 study that uses previously collected Whole Genome Sequencing (WGS) data from a single adult participant to evaluate the feasibility of a deterministic bioenergetic simulation model. The study does not involve clinical interventions, treatments, or prospective specimen collection. All analyses are performed on existing genomic data in a secure computational environment. The purpose of this study is to determine whether a physics-based metabolic model can successfully integrate individual genomic constraints to generate personalized, hypothesis-driven insights about metabolic pathways. The study focuses on model feasibility and computational performance, not clinical outcomes. No medications, diets, or behavioral interventions are administered or evaluated.

Study Locations (1)

New York

  • Bioactify LLC - Wappingers Falls

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2026-03-05
Est. Completion 2027-03

Sponsor

Bioactify

1 total trials

What the Registry Record Tells You About NCT07462234

The ClinicalTrials.gov registry entry for NCT07462234 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bioactify, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Computational Modeling of Individual Metabolic Pathways appearing as the primary indexed condition, and to 0 interventions.

NCT07462234 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07462234 about?

NCT07462234 is a clinical study titled "Continuous N-of-1 Computational Feasibility Study of a Whole Genome Sequence". This is an observational, computational N-of-1 study that uses previously collected Whole Genome Sequencing (WGS) data from a single adult participant to evaluate the feasibility of a deterministic bioenergetic simulation model. The study does not involve clinical interventions, treatments, or prosp...

What is the current status of trial NCT07462234?

This trial is currently active not recruiting. The enrollment target is 1 participants. The study started on 2026-03-05. Estimated completion is 2027-03.

What conditions does trial NCT07462234 study?

This clinical trial studies the following conditions: Computational Modeling of Individual Metabolic Pathways.

Who is sponsoring clinical trial NCT07462234?

This trial is sponsored by Bioactify, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07462234 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.